Valuation : Terumo Corporation

Market Cap 3,794B 23.81B 20.43B 19.18B 17.52B 33.06B 2,271B 33.22B 227B 87.96B 1,145B 89.38B 87.44B P/E 2027 *
19.9x
P/E 2028 * 19.8x
Enterprise Value 3,849B 24.15B 20.73B 19.45B 17.77B 33.53B 2,303B 33.69B 230B 89.22B 1,162B 90.67B 88.7B EV / Sales 2027 *
3.06x
EV / Sales 2028 * 2.83x
Free-Float
97.07%
Yield 2027 *
1.44%
Yield 2028 * 1.58%
1 day-0.47%
1 week+3.56%
Current month+10.15%
1 month+13.83%
3 months+9.66%
6 months+25.03%
Current year+12.78%
1 week 2,526.5
Extreme 2526.5
2,645.5
1 month 2,177.5
Extreme 2177.5
2,689
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,708
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.47%+3.56%-3.25%+19.21% 23.81B
-1.95%-1.77%-14.72%+9.07% 197B
-0.92%-1.23%-0.96%+12.01% 118B
-1.61%+2.43%+10.93%+78.69% 62.55B
-2.00%-3.74%+27.02%+53.48% 52.4B
-0.23%+0.92%-3.09%-32.75% 51.81B
+1.19%-0.34%+17.71%-9.45% 33.57B
+1.00%+6.29% - - 30.34B
-0.11%-0.97%+42.44%-13.14% 24.63B
-0.56%-0.63%-5.91%+2.82% 23.09B
Average -0.55%+0.78%+7.80%+13.33% 61.74B
Weighted average by Cap. -1.07%+0.07%+0.59%+15.53%

Financials

2027 *2028 *
Net sales 1,256B 7.88B 6.76B 6.35B 5.8B 10.94B 752B 10.99B 75.13B 29.11B 379B 29.59B 28.94B 1,336B 8.38B 7.2B 6.75B 6.17B 11.64B 800B 11.7B 79.92B 30.97B 403B 31.48B 30.79B
Net income 189B 1.18B 1.02B 954M 871M 1.64B 113B 1.65B 11.29B 4.38B 56.98B 4.45B 4.35B 191B 1.2B 1.03B 966M 883M 1.67B 114B 1.67B 11.44B 4.43B 57.71B 4.5B 4.41B
Net Debt 54.63B 343M 294M 276M 252M 476M 32.69B 478M 3.27B 1.27B 16.49B 1.29B 1.26B -16.66B -105M -89.74M -84.23M -76.93M -145M -9.97B -146M -997M -386M -5.03B -393M -384M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
27/08/26 ¥2,560.00 -0.47% 2,949,800
26/08/26 ¥2,572.00 -0.94% 3,286,000
25/08/26 ¥2,596.50 +0.04% 3,106,200
24/08/26 ¥2,595.50 +1.03% 3,082,000
21/08/26 ¥2,569.00 -0.29% 4,562,800
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,572.00JPY
Average target price
3,133.08JPY
Spread / Average Target
+21.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock